These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4825335)

  • 1. [Uridine-5-diphosphoglucose in the therapy of hepatopathies of diverse etiology].
    De las Casas Alonso P; Carballo García L; Silverio García C
    Rev Esp Enferm Apar Dig; 1974 Mar; 42(5):561-74. PubMed ID: 4825335
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uridine-diphosphoglucose in cirrhotic processes].
    Betancor León P
    Rev Esp Enferm Apar Dig; 1973 Feb; 39(4):463-78. PubMed ID: 4695936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Open clinical experience with uridine-diphosphoglucose in icteric hepatopathies of acute and chronic course].
    Güemes Díaz F; Conesa Picó OR; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1973 May; 40(3):327-34. PubMed ID: 4792335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Open clinical experience with uridine-diphosphoglucose in icterigenous liver diseases of acute and chronic course].
    Guemes Díaz F; Conesa Picó OR; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1973 May; 39(3):327-34. PubMed ID: 4712002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of UDPG, glutathione and vitamin B 12 therapy on various liver function indices in patients with liver cirrhosis].
    Coltorti M
    Clin Ter; 1975 Feb; 72(4):323-35. PubMed ID: 1222512
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the changes in some laboratory parameters in liver disease patients treated with Toxepasi Complex].
    Lenzi S
    Minerva Med; 1976 Sep; 67(46):2961-74. PubMed ID: 967362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies of the effect of a phosphorylated glycoderivative in acute viral hepatitis].
    Fiori GP; Mazza L
    Minerva Med; 1976 Mar; 67(12):132-40. PubMed ID: 1256689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic trial of uridine diphosphoglucose (UDPG) in physiological hyperbilirubinemia in newborn infants].
    Salazar De Sousa J; Sanches N; Pages MV
    Minerva Pediatr; 1975 Jun; 27(20):1162-5. PubMed ID: 1134472
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperbilirubinemia due to halothane in guinea pig. Protective effect of uridine diphosphoglucose].
    Vagelli A
    Minerva Anestesiol; 1974 Oct; 40(10):494-7. PubMed ID: 4420158
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new multienzyme complex. Clinical trial in hepatitis and cirrhosis].
    Ribet A; Vidal JL
    Nouv Presse Med; 1972 Nov; 1(42):2843-4. PubMed ID: 4663747
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sense and nonsense of liver disease therapy].
    Wildhirt E
    Med Welt; 1970 Jun; 26():1175-8. PubMed ID: 5522884
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uridine diphosphate glucose in acute viral hepatitis].
    Crispo C; Perruna F; Di Nicuolo G; Rosiello A
    Minerva Med; 1982 Feb; 73(5):187-90. PubMed ID: 7038553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of therapy of active chronic hepatopathies with 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Apr; 24(8):Suppl:124-6. PubMed ID: 5802052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic trials with essential phospholipids in various liver diseases].
    Alcalá-Santaella R; Fernández-Pacheco A; García García FJ; Alvarez Fernández E
    Rev Esp Enferm Apar Dig; 1972; 38(2):247-60. PubMed ID: 5073060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic results in active chronic hepatopathies using 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:124-6. PubMed ID: 5402568
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
    Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
    Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative evaluation of biochemical tests to determine the activity of the pathological process in patients with chronic hepatitis and cirrhosis of the liver who are receiving glucocorticoid therapy].
    Shul'man VSh; Tatarinova OM; Barenblat GZ
    Ter Arkh; 1969 Nov; 41(11):88-93. PubMed ID: 5384756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.